Cargando…

Overcoming the On‐Target Toxicity in Antibody‐Mediated Therapies via an Indirect Active Targeting Strategy

Antibody‐based therapies could be led astray when target receptors are expressed on nontarget sites, and the on‐target toxicity poses critical challenges to clinical applications. Here, a biomimetic indirect active targeting (INTACT) strategy is proposed based on receptor expression disparities betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Zhongjie, Wang, Xiaoyou, Tang, Mei, Wu, Jin, Zhang, Jiexuan, Liu, Xinlong, Gao, Feiyan, Fu, Yu, Tang, Peng, Li, Chong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037698/ https://www.ncbi.nlm.nih.gov/pubmed/36683161 http://dx.doi.org/10.1002/advs.202206912

Ejemplares similares

Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective
por: Li, Mengyu, et al.
Publicado: (2022)

Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies
por: Sun, Shangjun, et al.
Publicado: (2018)

Targeted multidrug delivery system to overcome chemoresistance in breast cancer
por: Tang, Yuan, et al.
Publicado: (2017)

Molecular Mechanism of Overcoming Host Resistance by the Target of Rapamycin Gene in Leptographium qinlingensis
por: An, Huanli, et al.
Publicado: (2022)

Membrane-targeted strategies for modulating APP and Aβ-mediated toxicity
por: Price, Katherine A, et al.
Publicado: (2009)

CircIFNGR2 enhances proliferation and migration of CRC and induces cetuximab resistance by indirectly targeting KRAS via sponging to MiR-30b
por: Zhang, Qi, et al.
Publicado: (2023)

Telomerase-Mediated Strategy for Overcoming Non–Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance
por: Mender, Ilgen, et al.
Publicado: (2018)

Macrophage membrane-mediated targeted drug delivery for treatment of spinal cord injury regardless of the macrophage polarization states
por: Tang, Wei, et al.
Publicado: (2021)

Targeting mutant p53 for cancer therapy: direct and indirect strategies
por: Hu, Jiahao, et al.
Publicado: (2021)

Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers
por: Esapa, Benjamina, et al.
Publicado: (2023)

Thinking Outside the Bug: Molecular Targets and Strategies to Overcome Antibiotic Resistance
por: Monserrat-Martinez, Ana, et al.
Publicado: (2019)

Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis
por: Minami, Toshiyuki, et al.
Publicado: (2013)

Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance—A Mini Review
por: Geisslinger, Franz, et al.
Publicado: (2020)

Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance
por: Liu, Shuya, et al.
Publicado: (2020)

Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
por: Nguyen, Ngoc Minh, et al.
Publicado: (2022)

Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies
por: Kang, Hyunkoo, et al.
Publicado: (2022)

Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs
por: Gámez-Chiachio, Manuel, et al.
Publicado: (2022)

Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors
por: Masucci, Maria Teresa, et al.
Publicado: (2023)

Folate Receptor Beta as a Direct and Indirect Target for Antibody-Based Cancer Immunotherapy
por: Roy, Allison G., et al.
Publicado: (2021)

Overcoming vaccine hesitancy by multiplex social network targeting: an analysis of targeting algorithms and implications
por: Fügenschuh, Marzena, et al.
Publicado: (2023)

Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
por: Zhang, Jiaxin, et al.
Publicado: (2022)

Two ways to overcome the three social dilemmas of indirect reciprocity
por: Okada, Isamu
Publicado: (2020)

Modeling the dynamics of antibody–target binding in living tumors
por: Tang, Yu, et al.
Publicado: (2020)

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
por: Al Ojaimi, Yara, et al.
Publicado: (2022)

Antibody-Mediated “Universal” Osteoclast Targeting Platform using Calcitonin as a Model Drug
por: Newa, Madhuri, et al.
Publicado: (2011)

hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a
por: He, Bing, et al.
Publicado: (2016)

Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy
por: Warkentin, Alexander A, et al.
Publicado: (2014)

Targeting Autophagy to Overcome Human Diseases
por: Condello, Maria, et al.
Publicado: (2019)

Targeting Notch to overcome radiation resistance
por: Yahyanejad, Sanaz, et al.
Publicado: (2015)

Targeting Immune-Mediated Dormancy: A Promising Treatment of Cancer
por: Wang, Hao-fan, et al.
Publicado: (2019)

Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer
por: Cao, Yaoquan, et al.
Publicado: (2023)

Overcoming chemotherapy resistance via simultaneous drug-efflux circumvention and mitochondrial targeting
por: Zhou, Minglu, et al.
Publicado: (2019)

Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
por: Chandrasekaran, Sanjay, et al.
Publicado: (2021)

Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer
por: Dazio, Giulia, et al.
Publicado: (2022)

Editorial: Strategies to overcome tumor evasion and resistance to immunotherapies by targeting immune suppressor cells
por: Saida, Yu, et al.
Publicado: (2023)

Drug Delivery Strategies and Nanozyme Technologies to Overcome Limitations for Targeting Oxidative Stress in Osteoarthritis
por: Aldrich, Jessica Lee, et al.
Publicado: (2023)

Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
por: Yu, Shengnan, et al.
Publicado: (2019)

Overcoming Resistance to AC0010, a Third Generation of EGFR Inhibitor, by Targeting c-MET and BCL-2
por: Xu, Wanhong, et al.
Publicado: (2018)

Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance
por: Wang, He, et al.
Publicado: (2014)

MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
por: Birsoy, Kivanc, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0gujd41mci982kree6btod8ke4